FDA Approved: DIHYDROERGOTAMINE MESYLATE — Original Application (Provepharm Inc.)

View source ↗

Summary

FDA approved an original ANDA for dihydroergotamine mesylate from Provepharm Inc., providing a generic option for treating migraines. This represents a routine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Dihydroergotamine mesylate (Dihydroergotamine Mesylate)

Snippet

ORIG AP for DIHYDROERGOTAMINE MESYLATE (DIHYDROERGOTAMINE MESYLATE)